Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AUROBINDO PHARMA LTD. - Completion Of US FDA Inspection At Our Unit VI - B
Download announcement < Back
30 Sep 2023
The US FDA inspected the Company&apos;&apos;s Unit VI-B, a formulation facility from September 22 to September 29, 2023 and at the end of the inspection a Form 483 was issued with one observation which is procedural in nature.
View all announcements for AUROBINDO PHARMA LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips